ACP
PODD icon

Acuta Capital Partners’s Insulet PODD Stock Holding History

Acuta Capital Partners’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-75,000
Closed -$2.27M – 76
2016
Q2 		$2.27M Buy
+75,000
New +$2.33M 1.09% 26
2015
Q2 		– Sell
-62,265
Closed -$2.08M – 57
2015
Q1 		$2.08M Buy
+62,265
New +$2.1M 1.75% 20

Other funds holding PODD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
VM
Valinor Management New York $32.2M AUM 44.16% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Acuta Capital Partners's PODD Position: Q3 2016 in Review

Acuta Capital Partners sold out of Insulet (PODD) in Q3 2016, closing a stake of 75,000 shares — an estimated $2.27M sold.

Acuta Capital Partners first reported a position in PODD in Q1 2015 and held it in 2 quarters. The position peaked at $2.27M in Q2 2016. 177 funds tracked by Wall St. Rank hold PODD as of Q3 2016.

  • Acuta Capital Partners reported no remaining Insulet position as of Q3 2016 after selling out during the quarter.
  • Acuta Capital Partners sold 75,000 Insulet shares in Q3 2016, an estimated $2.27M.
  • Acuta Capital Partners first reported a position in Insulet in Q1 2015 and held it in 2 quarters.
  • Acuta Capital Partners's Insulet position peaked at $2.27M in Q2 2016.
  • 177 funds tracked by Wall St. Rank held Insulet as of Q3 2016.

Based on Acuta Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.